Criminal Code Regulation 2005 (ACT)
Criminal Code Regulation 2005
SL2005-2
made under the
Criminal Code 2002
Republication No 14
Effective: 15 August 2019
Republication date: 15 August 2019
Last amendment made by A2019‑23
About this republication
The republished law
This is a republication of the Criminal Code Regulation 2005, made under the Criminal Code 2002 (including any amendment made under the Legislation Act 2001, part 11.3 (Editorial changes)) as in force on 15 August 2019. It also includes any commencement, amendment, repeal or expiry affecting this republished law to 15 August 2019.
The legislation history and amendment history of the republished law are set out in endnotes 3 and 4.
Kinds of republications
The Parliamentary Counsel’s Office prepares 2 kinds of republications of ACT laws (see the ACT legislation register at type="disc">
authorised republications to which the Legislation Act 2001 applies
unauthorised republications.
The status of this republication appears on the bottom of each page.
Editorial changes
The Legislation Act 2001, part 11.3 authorises the Parliamentary Counsel to make editorial amendments and other changes of a formal nature when preparing a law for republication. Editorial changes do not change the effect of the law, but have effect as if they had been made by an Act commencing on the republication date (see Legislation Act 2001, s 115 and s 117). The changes are made if the Parliamentary Counsel considers they are desirable to bring the law into line, or more closely into line, with current legislative drafting practice.
This republication includes amendments made under part 11.3 (see endnote 1).
Uncommenced provisions and amendments
If a provision of the republished law has not commenced, the symbol U appears immediately before the provision heading. Any uncommenced amendments that affect this republished law are accessible on the ACT legislation register ( For more information, see the home page for this law on the register.
Modifications
If a provision of the republished law is affected by a current modification, the symbol M appears immediately before the provision heading. The text of the modifying provision appears in the endnotes. For the legal status of modifications, see the Legislation Act 2001, section 95.
Penalties
At the republication date, the value of a penalty unit for an offence against this law is $160 for an individual and $810 for a corporation (see Legislation Act 2001, s 133).
Criminal Code Regulation 2005
made under the
Criminal Code 2002
Contents
Page
Part 1 Preliminary
1 Name of regulation 2
3 Dictionary 2
4 Notes 2
Part 2 Serious drugs offences
5 Controlled drugs—Code, s 600, def controlled drug 3
6 Controlled plants—Code, s 600, def controlled plant 3
7 Controlled precursors—Code, s 600, def controlled precursor 4
8 Quantities of controlled drugs, plants and precursors—Code, s 601 (1) 5
9 Quantities of controlled drugs in mixtures—Code, s 601 (2) 8
Schedule 1 Controlled drugs 9
Part 1.1 Controlled medicines 9
Part 1.2 Prohibited substances 15
Schedule 2 Controlled plants 26
Schedule 3 Controlled precursors 28
Dictionary33
Endnotes
1 About the endnotes 34
2 Abbreviation key 34
3 Legislation history 35
4 Amendment history 37
5 Earlier republications 39
6 Expired transitional or validating provisions 40
Criminal Code Regulation 2005
made under the
Criminal Code 2002
Part 1Preliminary
Name of regulation
This regulation is the Criminal Code Regulation 2005.
Dictionary
The dictionary at the end of this regulation is part of this regulation.
Note 1The dictionary at the end of this regulation defines certain terms used in this regulation.
Note 2A definition in the dictionary applies to the entire regulation unless the definition, or another provision of the regulation, provides otherwise or the contrary intention otherwise appears (see Legislation Act, s 155 and s 156 (1)).
Notes
A note included in this regulation is explanatory and is not part of this regulation.
NoteSee the Legislation Act, s 127 (1), (4) and (5) for the legal status of notes.
Part 2Serious drugs offences
Controlled drugs—Code, s 600, def controlled drug
(1)A substance mentioned in schedule 1 is prescribed.
(2)The following substances (each of which is a related drug) are also prescribed:
(a)a form of a drug mentioned in schedule 1, whether natural or synthetic, and the salts, derivatives and isomers of that drug and any salt of those derivatives and isomers;
(b)a drug that is in a class of drugs mentioned in schedule 1, whether natural or synthetic, and the salts, derivatives and isomers of that drug and any salt of those derivatives and isomers;
(c)an analogue in relation to a drug mentioned in schedule 1, which includes any substance having a substantially similar chemical structure to the drug, but differing in elemental composition due to the addition, deletion or replacement of any substituent element or group;
(d)a homologue in relation to a drug mentioned in schedule 1, which includes any substance which differs from that drug by one or more carbon containing groups (including methylene groups) in that chemical structure;
(e)a substance containing or mixed with a substance mentioned in schedule 1.
Controlled plants—Code, s 600, def controlled plant
A growing plant under schedule 2 is a controlled plant.
Controlled precursors—Code, s 600, def controlled precursor
(1)A substance mentioned in schedule 3 is prescribed.
(2)The following substances (each of which is a related precursor) are also prescribed:
(a)a preparation, admixture, extract or other substance containing any proportion of a substance mentioned in schedule 3;
(b)a substance that is 1 of the following in relation to a substance mentioned in schedule 3:
(i)acetal;
(ii)acetate;
(iii)acid chloride;
(iv)amide;
(v)anhydride;
(vi)diol;
(vii)epoxide;
(viii)ester;
(ix)ether;
(x)halogen substituent;
(xi)hydroxide;
(xii)imine;
(xiii)isomer;
(xiv)ketal;
(xv)nitrile;
(xvi)oxime;
(xvii)salt;
(c)any other analogue or derivative of a substance mentioned in schedule 3.
Quantities of controlled drugs, plants and precursors—Code, s 601 (1)
(1)For a controlled drug under schedule 1—
(a)a trafficable quantity of the drug is the quantity under the schedule, column 3 for the drug; and
(b)a commercial quantity of the drug is the quantity under the schedule, column 4 for the drug; and
(c)a large commercial quantity of the drug is the quantity under the schedule, column 5 for the drug.
(2)For a related drug—
(a)a trafficable quantity is the quantity mentioned in schedule 1, column 3 for—
(i)the drug to which it is related; or
(ii)if it is related to more than 1 drug—the drug to which it is related that has the smallest quantity mentioned in schedule 1, column 3; and
(b)a commercial quantity is the quantity mentioned in schedule 1, column 4 for—
(i)the drug to which it is related; or
(ii)if it is related to more than 1 drug—the drug to which it is related that has the smallest quantity mentioned in schedule 1, column 3; and
(c)a large commercial quantity is the quantity mentioned in schedule 1, column 5 for—
(i)the drug to which it is related; or
(ii)if it is related to more than 1 drug—the drug to which it is related that has the smallest quantity mentioned in schedule 1, column 3.
Example—par (a) (ii), par (b) (ii) and par (c) (ii)
Drug X is a related drug that is related to—
· Morphine (sch 1, pt 1.1, item 49); and
· Pethidine (sch 1, pt 1.1, item 60).
In sch 1, col 3, the quantity for Morphine is 2.00g and the quantity for Pethidine is 10.00g. Because the Morphine quantity is smaller than the Pethidine quantity, Morphine is the relevant drug for working out the quantities for drug X. Therefore, a trafficable quantity of drug X is 2.00g, a commercial quantity of drug X is 0.75kg and a large commercial quantity of drug X is 1.50kg.
(3)For a controlled plant—
(a)a trafficable quantity of the plant is the quantity under schedule 2, column 3 for the plant; and
(b)a commercial quantity of the plant is the quantity under schedule 2, column 4 for the plant; and
(c)a large commercial quantity of the plant is the quantity under schedule 2, column 5 for the plant.
(4)For a controlled precursor—
(a)a commercial quantity of the precursor is the quantity under schedule 3, column 3 for the precursor; and
(b)a large commercial quantity of the precursor is the quantity under schedule 3, column 4 for the precursor.
(5)For a related precursor—
(a)a commercial quantity is the quantity mentioned in schedule 3, column 3 for—
(i)the precursor to which it is related; or
(ii)if it is related to more than 1 precursor—the precursor to which it is related that has the smallest quantity mentioned in schedule 3, column 3; and
(b)a large commercial quantity is the quantity mentioned in schedule 3, column 4 for—
(i)the precursor to which it is related; or
(ii)if it is related to more than 1 precursor—the precursor to which it is related that has the smallest quantity mentioned in schedule 3, column 3.
Example—par (a) (ii) and par (b) (ii)
Precursor X is a related precursor that is related to—
· Ammonia (sch 3, item 8); and
· Calcium (sch 3, item 20).
In sch 3, col 3, the quantity for Ammonia is 1.50kg and the quantity for Calcium is 0.25kg. Because the Calcium quantity is smaller than the Ammonia quantity, Calcium is the relevant precursor for working out the quantities for precursor X. Therefore, a commercial quantity of precursor X is 0.25kg and a large commercial quantity of precursor X is 0.50kg.
(6)In this section:
related drug—see section 5 (2).
related precursor—see section 7 (2).
Quantities of controlled drugs in mixtures—Code, s 601 (2)
(1)For the Code, section 601 (2) (a)—
(a)the quantity under schedule 1, column 3 for a drug is a trafficable quantity of the pure form of the drug (or a related drug); and
(b)the quantity under schedule 1, column 4 for a drug is a commercial quantity of the pure form of the drug (or a related drug); and
(c)the quantity under schedule 1, column 5 for a drug is a large commercial quantity of the pure form of the drug (or a related drug).
(2)For the Code, section 601 (2) (b)—
(a)the quantity under schedule 1, column 3 for a drug is a trafficable quantity of the mixture containing the drug (or a related drug); and
(b)the quantity under schedule 1, column 4 for a drug is a commercial quantity of the mixture containing the drug (or a related drug); and
(c)the quantity under schedule 1, column 5 for a drug is a large commercial quantity of the mixture containing the drug (or a related drug).
Schedule 1Controlled drugs
(see s 5, s 8 (1) and (2), s 9)
NoteThis schedule is divided into pt 1.1 (Controlled medicines) and pt 1.2 (Prohibited substances). These terms are not relevant for the Criminal Code but are terms used in the Medicines, Poisons and Therapeutic Goods Act 2008.
Part 1.1Controlled medicines
| column 1 item | column 2 substance | column 3 trafficable quantity | column 4 commercial quantity | column 5 large commercial quantity |
| 1 | Acetyldihydrocodeine | 15.00 | 7.50 | 15.00 |
| 2 | Acetylmethadol | 15.00 | 7.50 | 15.00 |
| 3 | Acetylmorphines | 2.00 | 1.00 | 2.00 |
| 4 | Alfentanil | 3.00 | 1.50 | 3.00 |
| 5 | Alphacetylmethadol | 10.00 | 5.00 | 10.00 |
| 6 | Alphaprodine | 25.00 | 12.50 | 25.00 |
| 7 | Amphetamine | 6.00 | 3.00 | 6.00 |
| 8 | Amylobarbitone, except if packed and labelled for injection | 125.00 | 62.50 | 125.00 |
| 9 | Anileridine | 15.00 | 7.50 | 15.00 |
| 10 | Benzylmorphine | 7.50 | 3.75 | 7.50 |
| 11 | Bezitramide | 7.50 | 3.75 | 7.50 |
| 12 | Buprenorphine | 0.06 | 0.03 | 0.06 |
| 13 | Butobarbitone | 125.00 | 62.50 | 125.00 |
| 14 | Butorphanol | 5.00 | 2.50 | 5.00 |
| 15 | Carfentanyl | 0.0075 | 0.00375 | 0.0075 |
| 16 | Cocaine | 6.00 | 3.00 | 6.00 |
| 17 | Codeine, except if compounded with 1 or more other medicaments— | |||
| (a) in divided preparations containing 30mg or less of codeine per dosage unit; or | ||||
| (b) in undivided preparations containing 1% or less of codeine | 125.00 | 62.50 | 125.00 | |
| 18 | Codeine-N-oxide | 15.00 | 7.50 | 15.00 |
| 19 | 4-Cyano-1-methyl-4-phenylpiperidine (Pethidine intermediate A) | 3.00 | 1.50 | 3.00 |
| 20 | Cyclobarbitone | 125.00 | 62.50 | 125.00 |
| 21 | Dexamphetamine | 6.00 | 3.00 | 6.00 |
| 22 | Dextromoramide | 5.00 | 2.50 | 5.00 |
| 23 | Dextropropoxyphene, except— | |||
| (a) in divided preparations containing 135mg or less of dextropropoxyphene per dosage unit; or | ||||
| (b) in liquid preparations containing 2.5% or less of dextropropoxyphene | 27.00 | 13.50 | 27.00 | |
| 24 | Difenoxin, except in preparations containing, per dosage unit, 0.5mg or less of difenoxin and a quantity of atropine sulphate equivalent to at least 5% of the dose of difenoxin | 0.60 | 0.30 | 0.60 |
| 25 | Dihydrocodeine, except if compounded with 1 or more other medicaments— | |||
| (a) in divided preparations containing not more than 100mg of dihydrocodeine per dosage unit; or | ||||
| (b) in undivided preparations with a concentration of not more than 2.5% of dihydrocodeine | 250.00 | 125.00 | 250.00 | |
| 26 | Dihydromorphine | 250.00 | 125.00 | 250.00 |
| 27 | Diphenoxylate, except in preparations containing, per dosage unit, 2.5mg or less of diphenoxylate and a quantity of atropine sulphate equivalent to at least 1% of the dose of diphenoxylate | 125.00 | 62.50 | 125.00 |
| 28 | Dipipanone | 125.00 | 62.50 | 125.00 |
| 29 | Dronabinol | 25.00 | 12.50 | 25.00 |
| 30 | Drotebanol | 5.00 | 2.50 | 5.00 |
| 31 | Ethylamphetamine | 6.00 | 3.00 | 6.00 |
| 32 | Ethylmorphine, except if compounded with 1 or more other medicaments— | |||
| (a) in divided preparations containing not more than 100mg of ethylmorphine per dosage unit; or | ||||
| (b) in undivided preparations with a concentration of not more than 2.5% of ethylmorphine | 5.00 | 2.50 | 5.00 | |
| 33 | Fentanyl | 0.0075 | 0.00375 | 0.0075 |
| 34 | Flunitrazepam | 30.00 | 15.00 | 30.00 |
| 35 | Hydrocodone | 5.00 | 2.50 | 5.00 |
| 36 | Hydromorphinol | 5.00 | 2.50 | 5.00 |
| 37 | Hydromorphone | 5.00 | 2.50 | 5.00 |
| 38 | Ketamine | 6.00 | 3.00 | 6.00 |
| 39 | Levamphetamine | 6.00 | 3.00 | 6.00 |
| 40 | Levomethamphetamine | 6.00 | 3.00 | 6.00 |
| 41 | Levomoramide | 5.00 | 2.50 | 5.00 |
| 42 | Levorphanol | 1.50 | 0.75 | 1.50 |
| 43 | Methadone | 400.00 | 200.00 | 400.00 |
| 44 | Methylamphetamine | 6.00 | 3.00 | 6.00 |
| 45 | Methyldihydromorphine | 5.00 | 2.50 | 5.00 |
| 46 | Methylphenidate | 6.00 | 3.00 | 6.00 |
| 47 | 1-Methyl-4-phenylpiperidine-4-carboxylic Acid (Pethidine intermediate C) | 3.00 | 1.50 | 3.00 |
| 48 | Morphine | 20.00 | 10.00 | 20.00 |
| 49 | Morphine Methobromide | 30.00 | 15.00 | 30.00 |
| 50 | Morphine-N-oxide | 30.00 | 15.00 | 30.00 |
| 51 | Nabilone | 0.60 | 0.30 | 0.60 |
| 52 | Norcodeine | 500.00 | 250.00 | 500.00 |
| 53 | Normethadone | 7.50 | 3.75 | 7.50 |
| 54 | Opium in any form, except the alkaloids noscapine and papaverine | 30.00 | 15.00 | 30.00 |
| 55 | Oxycodone | 7.50 | 3.75 | 7.50 |
| 56 | Oxymorphone | 5.00 | 2.50 | 5.00 |
| 57 | Pentazocine | 125.00 | 62.50 | 125.00 |
| 58 | Pentobarbitone, except if packed and labelled for injection | 125.00 | 62.50 | 125.00 |
| 59 | Pethidine | 20.00 | 10.00 | 20.00 |
| 60 | Phendimetrazine | 15.00 | 7.50 | 15.00 |
| 61 | Phenmetrazine | 7.50 | 3.75 | 7.50 |
| 62 | Phenoperidine | 7.50 | 3.75 | 7.50 |
| 63 | 4-Phenylpiperidine-4-carboxylic Acid Ethyl Ester (Pethidine intermediate B) | 3.00 | 1.50 | 3.00 |
| 64 | Pholcodine, except if compounded with 1 or more other medicaments— | |||
| (a) in divided preparations containing not more than 100mg of pholcodine per dosage unit; or | ||||
| (b) in undivided preparations with a concentration of not more than 2.5% of pholcodine | 7.50 | 3.75 | 7.50 | |
| 65 | Piritramide | 1.50 | 0.75 | 1.50 |
| 66 | Poppy straw (concentrate of), that is the material arising when poppy straw has entered into a process for concentration of its alkaloids | 250.00 | 125.00 | 250.00 |
| 67 | Propiram | 5.00 | 2.50 | 5.00 |
| 68 | Quinalbarbitone | 125.00 | 62.50 | 125.00 |
| 69 | Racemoramide | 5.00 | 2.50 | 5.00 |
| 70 | Remifentanil | 0.30 | 0.15 | 0.30 |
| 71 | Secbutobarbitone | 125.00 | 62.50 | 125.00 |
| 72 | Sufentanil | 0.0075 | 0.00375 | 0.0075 |
| 73 | Thebacon | 5.00 | 2.50 | 5.00 |
| 74 | Thebaine | 5.00 | 2.50 | 5.00 |
| 75 | Tilidine | 3.00 | 1.50 | 3.00 |
Part 1.2Prohibited substances
| column 1 item | column 2 substance | column 3 trafficable quantity | column 4 commercial quantity | column 5 large commercial quantity |
| 1 | Acetorphine | 5.00 | 2.50 | 5.00 |
| 2 | Acetyl-alpha-methylfentanyl | 0.0075 | 0.00375 | 0.0075 |
| 3 | N-Acetylamphetamine | 6.00 | 3.00 | 6.00 |
| 4 | N-Acetylmethylamphetamine | 6.00 | 3.00 | 6.00 |
| 5 | Alkoxyamphetamines and bromo-substituted alkoxyamphetamines, except if separately mentioned in this part | 10.00 | 5.00 | 10.00 |
| 6 | Alkoxyamphetamines and substituted alkoxyamphetamines, except if separately mentioned in this part | 10.00 | 5.00 | 10.00 |
| 7 | Alkoxyphenethylamines and alkyl-substituted alkoxyphenethylamines, except if separately mentioned in this part | 10.00 | 5.00 | 10.00 |
| 8 | Alkoxyphenethylamines and substituted alkoxyphenethylamines, except if separately mentioned in this part | 10.00 | 5.00 | 10.00 |
| 9 | Alkoxythioamphetamines and substituted alkoxythioamphetamines, except if separately mentioned in this part | 10.00 | 5.00 | 10.00 |
| 10 | Allylprodine | 5.00 | 2.50 | 5.00 |
| 11 | Alphameprodine | 0.20 | 0.10 | 0.20 |
| 12 | Alphamethadol | 0.20 | 0.10 | 0.20 |
| 13 | Alpha-methylfentanyl | 0.0075 | 0.00375 | 0.0075 |
| 14 | N-[alpha-Methyl-3,4-(methylenedioxy)phenethyl]hydroxylamine (N-Hydroxy MDA) | 10.00 | 5.00 | 10.00 |
| 15 | Alpha-methylthiofentanyl | 0.0075 | 0.00375 | 0.0075 |
| 16 | Alpha-Pyrrolidinovalerophenone (a-PVP) | 6.00 | 3.00 | 6.00 |
| 17 | 2-Amino-1-(2,5-dimethoxy-4-methyl) phenylpropane (STP, DOM) | 10.00 | 5.00 | 10.00 |
| 18 | Benzethidine | 15.00 | 7.50 | 15.00 |
| 19 | Benzoylindoles, except if separately mentioned in this schedule | 300.00 | 30.00 | 150.00 |
| 20 | Benzylpiperazine (BZP) | 6.00 | 3.00 | 6.00 |
| 21 | Betacetylmethadol | 5.00 | 2.50 | 5.00 |
| 22 | Beta-hydroxyfentanyl | 0.0075 | 0.00375 | 0.0075 |
| 23 | Beta-hydroxy-3-methylfentanyl | 0.0075 | 0.00375 | 0.0075 |
| 24 | Betameprodine | 5.00 | 2.50 | 5.00 |
| 25 | Betamethadol | 5.00 | 2.50 | 5.00 |
| 26 | Betaprodine | 5.00 | 2.50 | 5.00 |
| 27 | 1-(8-Bromobenzo[1,2-b;4,5-b]difuran-4-yl)-2-aminopropane (Bromo Dragonfly) | 10.00 | 5.00 | 10.00 |
| 28 | 4-Bromo-2,5-dimethoxyamphetamine (DOB) | 10.00 | 5.00 | 10.00 |
| 29 | 4-Bromo-3,5-dimethoxyamphetamine | 10.00 | 5.00 | 10.00 |
| 30 | 4-Bromo-2,5-dimethoxyphenethylamine (2C-B) | 10.00 | 5.00 | 10.00 |
| 31 | 3-Bromo-4-methoxyamphetamine | 10.00 | 5.00 | 10.00 |
| 32 | 4-Bromo-3-methoxyamphetamine | 10.00 | 5.00 | 10.00 |
| 33 | Bufotenine | 10.00 | 5.00 | 10.00 |
| 34 | Cannabinomimetics (synthetic), except if separately mentioned in this schedule | 300.00 | 30.00 | 150.00 |
| 35 | Cannabis | 300.00 | 30.00 | 150.00 |
| 36 | Cannabis oil, except cannabis food products | 25.00 | 2.50 | 12.50 |
| 37 | Cannabis resin | 25.00 | 2.50 | 12.50 |
| 38 | Cathinone | 6.00 | 3.00 | 6.00 |
| 39 | 1-(3-Chlorophenyl)-piperazine (mCPP) | 6.00 | 3.00 | 6.00 |
| 40 | Clonitazene | 7.50 | 3.75 | 7.50 |
| 41 | Coca leaf | 30.00 | 15.00 | 30.00 |
| 42 | Codoxime | 15.00 | 7.50 | 15.00 |
| 43 | 4-Cyano-2-dimethylamino-4,4-diphenylbutane (Methadone intermediate) | 5.00 | 2.50 | 5.00 |
| 44 | Cyclohexylphenols, except if separately mentioned in this schedule | 300.00 | 30.00 | 150.00 |
| 45 | Desomorphine | 5.00 | 2.50 | 5.00 |
| 46 | Diampromide | 7.50 | 3.75 | 7.50 |
| 47 | Dibenzopyrans, except if separately mentioned in this schedule | 2.00 | 1.00 | 2.00 |
| 48 | Diethylthiambutene | 7.50 | 3.75 | 7.50 |
| 49 | N,N-Diethyltryptamine (DET) | 10.00 | 5.00 | 10.00 |
| 50 | Dimenoxadol | 125.00 | 62.50 | 125.00 |
| 51 | Dimepheptanol | 125.00 | 62.50 | 125.00 |
| 52 | 2,4-Dimethoxyamphetamine | 10.00 | 5.00 | 10.00 |
| 53 | 2,5-Dimethoxyamphetamine (DMA) | 10.00 | 5.00 | 10.00 |
| 54 | 3,4-Dimethoxyamphetamine | 10.00 | 5.00 | 10.00 |
| 55 | 2,5-Dimethoxy-4-ethoxyamphetamine | 10.00 | 5.00 | 10.00 |
| 56 | 3,4-Dimethoxy-5-ethoxyamphetamine | 10.00 | 5.00 | 10.00 |
| 57 | 4,5-Dimethoxy-2-ethoxyamphetamine | 10.00 | 5.00 | 10.00 |
| 58 | 2,5-Dimethoxy-4-ethylamphetamine (DOET) | 10.00 | 5.00 | 10.00 |
| 59 | 2,5-Dimethoxy-4-ethylthiophenethylamine (2C-T-2) | 10.00 | 5.00 | 10.00 |
| 60 | 2,5-Dimethoxy-4-iodophenethylamine (2C-I) | 10.00 | 5.00 | 10.00 |
| 61 | 2,3-Dimethoxy-4,5-methylenedioxyamphetamine | 10.00 | 5.00 | 10.00 |
| 62 | 2,5-Dimethoxy-3,4-methylenedioxyamphetamine | 10.00 | 5.00 | 10.00 |
| 63 | 3,4-Dimethoxyphenylethylamine | 10.00 | 5.00 | 10.00 |
| 64 | 2,5-Dimethoxy-4-(N)-propylthiophenethylamine (2C-T-7) | 10.00 | 5.00 | 10.00 |
| 65 | 3-(2-Dimethylaminoethyl)-4-hydroxyindole (Psilocine, Psilotsin) | 2.00 | 1.00 | 2.00 |
| 66 | 3-(1,2-Dimethylheptyl)-1-hydroxy-7,8,9,10-tetrahydro-6,6,9-trimethyl-6H-dibenzo[b,d]pyran (DMHP) | 3.00 | 1.50 | 3.00 |
| 67 | Dimethylthiambutene | 7.50 | 3.75 | 7.50 |
| 68 | N,N-Dimethylamphetamine | 6.00 | 3.00 | 6.00 |
| 69 | N,N-Dimethyltryptamine (DMT) | 10.00 | 5.00 | 10.00 |
| 70 | Dioxaphetyl Butyrate | 5.00 | 2.50 | 5.00 |
| 71 | Ecgonine | 6.00 | 3.00 | 6.00 |
| 72 | 4,5-Ethylenedioxy-3-methoxyamphetamine | 10.00 | 5.00 | 10.00 |
| 73 | Ethylmethylthiambutene | 7.50 | 3.75 | 7.50 |
| 74 | Eticyclidine (PCE) | 0.0075 | 0.00375 | 0.0075 |
| 75 | Etonitazene | 7.50 | 3.75 | 7.50 |
| 76 | Etorphine | 7.50 | 3.75 | 7.50 |
| 77 | Etoxeridine | 7.50 | 3.75 | 7.50 |
| 78 | Fenethylline | 6.00 | 3.00 | 6.00 |
| 79 | 4-Fluoro-N-methylamphetamine (4-FMA) | 10.00 | 5.00 | 10.00 |
| 80 | 1-(5-Fluoropentyl)-3-(2-iodobenzoyl)indole (AM-694) | 300.00 | 30.00 | 150.00 |
| 81 | N-Formylamphetamine | 6.00 | 3.00 | 6.00 |
| 82 | N-Formylmethylamphetamine | 6.00 | 3.00 | 6.00 |
| 83 | Furethidine | 1.50 | 0.75 | 1.50 |
| 84 | Harmaline | 20.00 | 10.00 | 20.00 |
| 85 | Harmine | 20.00 | 10.00 | 20.00 |
| 86 | Heroin | 5.00 | 2.50 | 5.00 |
| 87 | 3-Hexyl-1-hydroxy-7,8,9,10-tetrahydro-6,6,9-trimethyl-6H-dibenzo[b,d]pyran (Parahexyl) | 5.00 | 2.50 | 5.00 |
| 88 | 4-Hydroxybutanoic acid (GHB) | 0.50 | 0.25 | 0.50 |
| 89 | 2-[(1r,3s)-3-Hydroxycyclohexyl]-5-(2-methylnonan-2-yl)phenol (Cannabicyclohexanol or CP 47, 497 C8 homologue) | 3.00 | 1.50 | 3.00 |
| 90 | 2-[(1r,3s)-3-Hydroxycyclohexyl]-5-(2-methyloctan-2-yl)phenol (CP 47,497) | 3.00 | 1.50 | 3.00 |
| 91 | Hydroxypethidine | 3.00 | 1.50 | 3.00 |
| 92 | Isomethadone | 5.00 | 2.50 | 5.00 |
| 93 | Ketobemidone | 5.00 | 2.50 | 5.00 |
| 94 | Levomethorphan | 5.00 | 2.50 | 5.00 |
| 95 | Levophenacylmorphan | 5.00 | 2.50 | 5.00 |
| 96 | Lysergic Acid | 0.003 | 0.0015 | 0.003 |
| 97 | Lysergide (LSD, LSD-25) | 0.003 | 0.0015 | 0.003 |
| 98 | Mecloqualone | 15.00 | 7.50 | 15.00 |
| 99 | Metazocine | 125.00 | 62.50 | 125.00 |
| 100 | Methaqualone | 7.50 | 3.75 | 7.50 |
| 101 | Methcathinone | 6.00 | 3.00 | 6.00 |
| 102 | 4-Methoxyamphetamine (PMA) | 10.00 | 5.00 | 10.00 |
| 103 | 5-Methoxy-alpha-methyltryptamine (5-MeO-AMT) | 10.00 | 5.00 | 10.00 |
| 104 | N-(2-Methoxybenzyl)-2,5-dimethoxy-4-bromophenethylamine (25B-NBOMe) | 10.00 | 5.00 | 10.00 |
| 105 | N-(2-Methoxybenzyl)-2,5-dimethoxy-4-chlorophenethylamine (25C-NBOMe) | 10.00 | 5.00 | 10.00 |
| 106 | N-(2-Methoxybenzyl)-2,5-dimethoxy-4-iodophenethylamine (25I-NBOMe) | 10.00 | 5.00 | 10.00 |
| 107 | N-(2-Methoxybenzyl)-2,5-dimethoxy-4-methylphenethylamine (25D-NBOMe) | 10.00 | 5.00 | 10.00 |
| 108 | N-(2-Methoxybenzyl)-2,5-dimethoxyphenethylamine (25H-NBOMe) | 10.00 | 5.00 | 10.00 |
| 109 | 4-Methoxymethylamphetamine (PMMA) | 10.00 | 5.00 | 10.00 |
| 110 | 2-Methoxy-3,4-methylenedioxyamphetamine | 10.00 | 5.00 | 10.00 |
| 111 | 5-Methoxy-3,4-methylenedioxyamphetamine | 10.00 | 5.00 | 10.00 |
| 112 | 2-Methoxy-4,5-methylenedioxyamphetamine | 10.00 | 5.00 | 10.00 |
| 113 | 4-Methoxy-2,3-methylenedioxyamphetamine | 10.00 | 5.00 | 10.00 |
| 114 | 2-Methoxy-3,4-methylenedioxyphenylethylamine | 10.00 | 5.00 | 10.00 |
| 115 | 3-Methoxy-4,5-methylenedioxyphenylethylamine | 10.00 | 5.00 | 10.00 |
| 116 | 4-Methoxyphenylethylamine | 10.00 | 5.00 | 10.00 |
| 117 | 2-(2-Methoxyphenyl)-1-(1-pentylindol-3-yl)ethanone (JWH-250) | 3.00 | 1.50 | 3.00 |
| 118 | 1-(4-Methoxyphenyl)piperazine (pMPP) | 6.00 | 3.00 | 6.00 |
| 119 | Methyl(2S,4aR,6aR,7R,9S,10aS,10bR)-9-acetoxy-6a,10b-dimethyl-4,10-dioxo-dodecahydro-2-(3-furyl)-2H-naphtho[2,1-c]pyran-7-carboxylate (Salvinorin A) | |||
| 120 | 4-Methylaminorex | 6.00 | 3.00 | 6.00 |
| 121 | Methyldesorphine | 5.00 | 2.50 | 5.00 |
| 122 | 3,4-Methylenedioxyamphetamine (MDA) | 10.00 | 5.00 | 10.00 |
| 123 | 3,4-Methylenedioxy-N-ethylamphetamine (MDEA) | 10.00 | 5.00 | 10.00 |
| 124 | 3,4-Methylenedioxymethcathinone (Methylone) | 10.00 | 5.00 | 10.00 |
| 125 | 3,4-Methylenedioxymethylamphetamine (MDMA) | 10.00 | 5.00 | 10.00 |
| 126 | 3,4-Methylenedioxypyrovalerone (MDPV) | 10.00 | 5.00 | 10.00 |
| 127 | 3-Methylfentanyl | 0.0075 | 0.00375 | 0.0075 |
| 128 | 4-Methylmethcathinone (Mephedrone) | 6.00 | 3.00 | 6.00 |
| 129 | N-Methyl-1-(3,4-Methylenedioxyphenyl)-2-Butanamine (MBDB) | 10.00 | 5.00 | 10.00 |
| 130 | 2-Methyl-3-morpholino-1,1-diphenylpropane Carboxylic Acid (Moramide intermediate) | 5.00 | 2.50 | 5.00 |
| 131 | 1-Methyl-4-phenyl-4-piperidinol propionate (MPPP) | 5.00 | 2.50 | 5.00 |
| 132 | 4-Methylthioamphetamine | 10.00 | 5.00 | 10.00 |
| 133 | 3-Methylthiofentanyl | 0.0075 | 0.00375 | 0.0075 |
| 134 | Metopon | 5.00 | 2.50 | 5.00 |
| 135 | Mitragynine | |||
| 136 | Morpheridine | 30.00 | 15.00 | 30.00 |
| 137 | (1-(2-Morpholin-4-ylethyl)indol-3-yl)-napthalen-1-ylmethanone (JWH-200) | 3.00 | 1.50 | 3.00 |
| 138 | Muscimol | 2.00 | 1.00 | 2.00 |
| 139 | Myrophine | 30.00 | 15.00 | 30.00 |
| 140 | Nalbuphine | 0.05 | 0.025 | 0.05 |
| 141 | Naphthoylindoles, except if separately mentioned in this schedule | 3.00 | 1.50 | 3.00 |
| 142 | Naphthoylpyrroles, except if separately mentioned in this schedule | 300.00 | 30.00 | 150.00 |
| 143 | Naphthylmethylindenes, except if separately mentioned in this schedule | 300.00 | 30.00 | 150.00 |
| 144 | Naphthylmethylindoles, except if separately mentioned in this schedule | 300.00 | 30.00 | 150.00 |
| 145 | Napthalen-1-yl-(1-butylindol-3-yl)methanone (JWH-073) | 3.00 | 1.50 | 3.00 |
| 146 | Nicocodine | 500.00 | 250.00 | 500.00 |
| 147 | Nicodicodine | 500.00 | 250.00 | 500.00 |
| 148 | Nicomorphine | 500.00 | 250.00 | 500.00 |
| 149 | Noracylmethadol | 5.00 | 2.50 | 5.00 |
| 150 | Norlevorphanol | 5.00 | 2.50 | 5.00 |
| 151 | Normorphine | 30.00 | 15.00 | 30.00 |
| 152 | Norpipanone | 15.00 | 7.50 | 15.00 |
| 153 | Para-fluorofentanyl | 0.005 | 0.0025 | 0.005 |
| 154 | 1-Pentyl-3-(4-methyl-1-napthoyl)indole (JWH-122) | 3.00 | 1.50 | 3.00 |
| 155 | 1-Pentyl-3-(1-naphthoyl)indole (JWH-018) | 3.00 | 1.50 | 3.00 |
| 156 | Phenadoxone | 15.00 | 7.50 | 15.00 |
| 157 | Phenampromide | 15.00 | 7.50 | 15.00 |
| 158 | Phenazocine | 1.50 | 0.75 | 1.50 |
| 159 | Phencyclidine (PCP) | 0.0075 | 0.00375 | 0.0075 |
| 160 | Phenethylamines, except if separately mentioned in this schedule | 300.00 | 30.00 | 150.00 |
| 161 | Phenomorphan | 7.50 | 3.75 | 7.50 |
| 162 | Phenylacetylindoles, except if separately mentioned in this schedule | 10.00 | 5.00 | 10.00 |
| 163 | 1-Phenylethyl-4-phenyl-4-piperidinol acetate (PEPAP) | 5.00 | 2.50 | 5.00 |
| 164 | Piminodine | 15.00 | 7.50 | 15.00 |
| 165 | Proheptazine | 1.50 | 0.75 | 1.50 |
| 166 | Properidine | 40.00 | 20.00 | 40.00 |
| 167 | Psilocybine | 2.00 | 1.00 | 2.00 |
| 168 | Racemethorphan | 5.00 | 2.50 | 5.00 |
| 169 | Racemorphan | 5.00 | 2.50 | 5.00 |
| 170 | Rolicyclidine (PHP, PCPY) | 0.0075 | 0.00375 | 0.0075 |
| 171 | Tenocyclidine (TCP) | 2.00 | 1.00 | 2.00 |
| 172 | Tetrahydrocannabinols (THC) and their alkyl homologues, except if separately mentioned in this schedule | 2.00 | 1.00 | 2.00 |
| 173 | 2,3,4,5-Tetramethoxyamphetamine | 10.00 | 5.00 | 10.00 |
| 174 | Thiofentanyl | 0.0075 | 0.00375 | 0.0075 |
| 175 | Trifluoromethylphenylpiperazine (TFMPP) | 6.00 | 3.00 | 6.00 |
| 176 | Trimeperidine | 15.00 | 7.50 | 15.00 |
| 177 | 3,4,5-Trimethoxyamphetamine (TMA) | 10.00 | 5.00 | 10.00 |
| 178 | 2,3,4-Trimethoxyamphetamine | 10.00 | 5.00 | 10.00 |
| 179 | 2,3,5-Trimethoxyamphetamine | 10.00 | 5.00 | 10.00 |
| 180 | 2,3,6-Trimethoxyamphetamine | 10.00 | 5.00 | 10.00 |
| 181 | 2,4,5-Trimethoxyamphetamine | 10.00 | 5.00 | 10.00 |
| 182 | 2,4,6-Trimethoxyamphetamine | 10.00 | 5.00 | 10.00 |
| 183 | 3,4,5-Trimethoxyphenethylamine (mescaline) and other substances structurally derived from methoxy-phenylethylamine, except— | |||
| (a) methoxyphenamine; or | ||||
| (b) if separately mentioned in this part | 10.00 | 5.00 | 10.00 | |
| 184 | 1-(3,4,5-Trimethoxyphenyl)-2-aminobutane | 10.00 | 5.00 | 10.00 |
| 185 | 2,4,5-Trimethoxyphenylethylamine | 10.00 | 5.00 | 10.00 |
Schedule 2Controlled plants
(see s 6, s 8 (3))
| column 1 item | column 2 controlled plant | column 3 trafficable quantity | column 4 commercial quantity | column 5 large commercial quantity |
| 1 | Amanita cothurnata | |||
| 2 | Amanita gemmata | |||
| 3 | Amanita muscaria | |||
| 4 | Amanita pantherina | |||
| 5 | other plants of species Amanita | |||
| 6 | Banisteria caapi | |||
| 7 | Banisteriopsis inebrians | |||
| 8 | Cannabis | 10 plants | 100 plants | 1 000 plants |
| 9 | Catha edulis | |||
| 10 | any plant of species Conocybe | |||
| 11 | any plant of species Erythroxylon | |||
| 12 | any plant of species Gymnopilus | |||
| 13 | Haemadictyon amazonicum | |||
| 14 | Lophophora williamsii | |||
| 15 | Mitragyna speciosa | |||
| 16 | Papaver orientale (Papaver bracteatum) | 500 plants | ||
| 17 | Papaver somniferum | 500 plants | ||
| 18 | Peganum harmala | |||
| 19 | Piptadenia macrocarpa | |||
| 20 | Piptadenia peregrina | |||
| 21 | Prestonia amazonica | |||
| 22 | any plant of species Psilocybe | |||
| 23 | Salvia divinorum | |||
| 24 | Stropharia cubensis |
Schedule 3Controlled precursors
(see s 7, s 8 (4), (5) and (6))
| column 1 item | column 2 controlled precursor | column 3 commercial quantity | column 4 large commercial quantity |
| 1 | Acetaldehyde | 0.50kg | 1.00kg |
| 2 | Acetic anhydride | 0.70kg | 1.40kg |
| 3 | N-Acetylanthranilic acid | 5.00kg | 10.00kg |
| 4 | Allylbenzene | 0.25L | 0.50L |
| 5 | Allylpyrocatechol | 0.10L | 0.20L |
| 6 | Alpha-phenylacetoacetonitrile | 0.50kg | 1.00kg |
| 7 | 4-Amino-butanoic acid | 1.50kg | 3.00kg |
| 8 | Ammonia | 1.50kg | 3.00kg |
| 9 | Ammonium formate | 0.50kg | 1.00kg |
| 10 | Anthranilic acid | 5.00kg | 10.00kg |
| 11 | Benzaldehyde | 0.50L | 1.00L |
| 12 | 1,3-Benzodioxole | 0.25L | 0.50L |
| 13 | Benzyl bromide | 0.50L | 1.00L |
| 14 | Benzyl chloride | 0.50L | 1.00L |
| 15 | Boron tribromide | 0.25L | 0.50L |
| 16 | Bromobenzene | 1.05kg | 2.10kg |
| 17 | 5-Bromo-1,3-benzodioxole | 0.25L | 0.50L |
| 18 | Bromo safrole | 0.30kg | 0.60kg |
| 19 | 1,4-Butanediol | 1.50L | 3.00L |
| 20 | Calcium | 0.25kg | 0.50kg |
| 21 | 1-Chlorophenyl-2-aminopropane | 1.25kg | 2.50kg |
| 22 | Chromic acid | 0.10L | 0.20L |
| 23 | Chromium trioxide | 0.10kg | 0.20kg |
| 24 | Ephedrine | 0.25kg | 0.50kg |
| 25 | Ergometrine | 0.0001kg | 0.0002kg |
| 26 | Ergotamine | 0.0002kg | 0.0004kg |
| 27 | Ethanamine | 0.50L | 1.00L |
| 28 | N-Ethylephedrine | 0.25kg | 0.50kg |
| 29 | Ethyl phenyl acetate | 0.50L | 1.00L |
| 30 | N-Ethylpseudoephedrine | 0.25kg | 0.50kg |
| 31 | Eugenol | 0.10L | 0.20L |
| 32 | Formaldehyde | 1.50kg | 3.00kg |
| 33 | Formamide | 0.50L | 1.00L |
| 34 | Gamma butyrolactone | 1.50L | 3.00L |
| 35 | Gamma hydroxybutanoic acid | 1.50L | 3.00L |
| 36 | Hydriodic acid | 0.65L | 1.30L |
| 37 | Hydrobromic acid | 0.25L | 0.50L |
| 38 | Hydrogen | 1.50kg | 3.00kg |
| 39 | Hydrogen chloride | 1.50kg | 3.00kg |
| 40 | Hydrogen sulfide | 1.50kg | 3.00kg |
| 41 | 4-Hydroxybutanal | 1.50L | 3.00L |
| 42 | 4-Hydroxy-butanoic acid lactone | 1.50L | 3.00L |
| 43 | 4-Hydroxy-butanoic acid nitrile | 1.50L | 3.00L |
| 44 | 4-Hydroxy pentanoic acid | 1.50L | 3.00L |
| 45 | 2-Hydroxytetrahydrofuran | 1.50L | 3.00L |
| 46 | Hypophosphite salts | 0.25 kg | 0.50kg |
| 47 | Hypophosphorous acid | 0.45L | 0.90L |
| 48 | Iodine | 0.25kg | 0.50kg |
| 49 | Isosafrole | 0.30L | 0.60L |
| 50 | Lithium | 0.25kg | 0.50kg |
| 51 | Lithium aluminium hydride | 0.05kg | 0.10kg |
| 52 | Lysergic acid | 0.00005kg | 0.0001kg |
| 53 | Magnesium | 0.25kg | 0.50kg |
| 54 | Mandellic acid | 0.50kg | 1.00kg |
| 55 | Mercuric chloride | 0.001kg | 0.002kg |
| 56 | Mercury | 0.001kg | 0.002kg |
| 57 | Methcathinone | 0.25kg | 0.50kg |
| 58 | Methylamine | 0.50L | 1.00L |
| 59 | Methylammonium salts | 0.25kg | 0.50kg |
| 60 | 3,4-Methylenedioxyphenylacetic acid | 0.10kg | 0.20kg |
| 61 | 3,4-Methylenedioxyphenylpropan-2-one (PMK) | 0.05kg | 0.10kg |
| 62 | N-Methyl ephedrine | 1.20kg | 2.40kg |
| 63 | N-Methylformamide | 0.50L | 1.00L |
| 64 | Methyl phenylacetate | 1.00kg | 2.00kg |
| 65 | N-Methylpseudoephedrine | 1.20kg | 2.40kg |
| 66 | Methylstyrene | 0.50L | 1.00L |
| 67 | Nitroethane | 0.50L | 1.00L |
| 68 | Nitromethane | 0.50L | 1.00L |
| 69 | Norpseudoephedrine | 2.15kg | 4.30kg |
| 70 | Palladium | 0.005kg | 0.01kg |
| 71 | Phenylacetamide | 0.50kg | 1.00kg |
| 72 | Phenylacetic acid | 0.50kg | 1.00kg |
| 73 | Phenylacetonitrile | 1.45L | 2.90L |
| 74 | Phenylacetyl chloride | 1.05L | 2.10L |
| 75 | Phenylalanine | 0.50kg | 1.00kg |
| 76 | 1-Phenyl-2-bromopropane | 0.50kg | 1.00kg |
| 77 | 1-Phenyl-2-chloropropane | 1.15kg | 2.30kg |
| 78 | 1-Phenyl-2-iodopropane | 0.50kg | 1.00kg |
| 79 | 1-Phenyl-2-nitropropene | 1.20kg | 2.40kg |
| 80 | 1-Phenyl-2-propanol | 0.90L | 1.80L |
| 81 | Phenylpropanolamine | 2.15kg | 4.30kg |
| 82 | 1-Phenyl-1-propanone | 0.25L | 0.50L |
| 83 | 1-Phenyl-2-propanone (BMK) | 1.00L | 2.00L |
| 84 | 1-Phenyl-2-propanone oxime | 1.00kg | 2.00kg |
| 85 | Phosphorus | 0.10kg | 0.20kg |
| 86 | Phosphorous acid | 1.10L | 2.20L |
| 87 | Piperidine | 0.35kg | 0.70kg |
| 88 | Piperonal | 0.30kg | 0.60kg |
| 89 | Platinum | 0.005kg | 0.010kg |
| 90 | Potassium | 0.25kg | 0.50kg |
| 91 | Propionic anhydride | 0.05L | 0.10L |
| 92 | Pseudoephedrine | 1.10kg | 2.20kg |
| 93 | Pyridine | 1.00L | 2.00L |
| 94 | 2-Pyrrolidone | 1.50L | 3.00L |
| 95 | Raney nickel | 0.05kg | 0.10kg |
| 96 | Safrole | 0.30L | 0.60L |
| 97 | Sassafras oil | 0.10L | 0.20L |
| 98 | Sodium | 0.25kg | 0.50kg |
| 99 | Sodium bis (2-methoxyethoxy) aluminium hydride | 0.05kg | 0.10kg |
| 100 | Sodium borohydride | 0.05kg | 0.10kg |
| 101 | Sodium cyanoborohydride | 0.05kg | 0.10kg |
| 102 | Thionyl chloride | 0.25kg | 0.50kg |
| 103 | Thorium | 1.00kg | 2.00kg |
Dictionary
(see s 3)
Note 1The Legislation Act contains definitions and other provisions relevant to this regulation.
Note 2For example, the Legislation Act, dict, pt 1, defines the following term:
· for.
Note 3Terms used in this regulation have the same meaning that they have in the Criminal Code (see Legislation Act, s 148). For example, the following term is defined in the Criminal Code, dict:
· cannabis (see s 600).
cannabis food product—see the Drugs of Dependence Act 1989, section 6.
Code means the Criminal Code.
derivative means a substance or compound made from another substance or compound.
Endnotes
About the endnotes
Amending and modifying laws are annotated in the legislation history and the amendment history. Current modifications are not included in the republished law but are set out in the endnotes.
Not all editorial amendments made under the Legislation Act 2001, part 11.3 are annotated in the amendment history. Full details of any amendments can be obtained from the Parliamentary Counsel’s Office.
Uncommenced amending laws are not included in the republished law. The details of these laws are underlined in the legislation history. Uncommenced expiries are underlined in the legislation history and amendment history.
If all the provisions of the law have been renumbered, a table of renumbered provisions gives details of previous and current numbering.
The endnotes also include a table of earlier republications.
Abbreviation key
A = Act NI = Notifiable instrument AF = Approved form o = order am = amended om = omitted/repealed amdt = amendment ord = ordinance AR = Assembly resolution orig = original ch = chapter par = paragraph/subparagraph CN = Commencement notice pres = present def = definition prev = previous DI = Disallowable instrument (prev...) = previously dict = dictionary pt = part disallowed = disallowed by the Legislative r = rule/subrule Assembly reloc = relocated div = division renum = renumbered exp = expires/expired R[X] = Republication No Gaz = gazette RI = reissue hdg = heading s = section/subsection IA = Interpretation Act 1967 sch = schedule ins = inserted/added sdiv = subdivision LA = Legislation Act 2001 SL = Subordinate law LR = legislation register sub = substituted LRA = Legislation (Republication) Act 1996 underlining = whole or part not commenced mod = modified/modification or to be expired
Legislation history
Criminal Code Regulation 2005 SL2005‑2
notified LR 4 March 2005
s 1, s 2 commenced 4 March 2005 (LA s 75 (1))
sch 1 pt 1.1 item 39 commenced 1 May 2005 (s 2 (2))
remainder commenced 6 March 2005 (s 2 (1) and see Criminal Code (Serious Drug Offences) Amendment Act 2004 A2004-56 s 2 and LA s 79)as amended by
Criminal Code Amendment Regulation 2007 (No 1) SL2007-7
notified LR 3 May 2007
s 1, s 2 commenced 3 May 2007 (LA s 75 (1))
remainder commenced 4 May 2007 (s 2)Justice and Community Safety Legislation Amendment Act 2007 A2007‑22 sch 1 pt 1.7
notified LR 5 September 2007
s 1, s 2 commenced 5 September 2007 (LA s 75 (1))sch 1 pt 1.7 commenced 6 September 2007 (s 2)
Medicines, Poisons and Therapeutic Goods Act 2008 A2008-26 sch 2 pt 2.7
notified LR 14 August 2008
s 1, s 2 commenced 14 August 2008 (LA s 75 (1))
sch 2 pt 2.7 commenced 14 February 2009 (s 2 and LA s 79)Criminal Code Amendment Regulation 2008 (No 1) SL2008-56
notified LR 22 December 2008
s 1, s 2 commenced 22 December 2008 (LA s 75 (1))
remainder commenced 23 December 2008 (s 2)Criminal Code Amendment Regulation 2009 (No 1) SL2009-25
notified LR 1 June 2009
s 1, s 2 commenced 1 June 2009 (LA s 75 (1))
remainder commenced 2 June 2009 (s 2)Crimes Legislation Amendment Act 2009 A2009-24 sch 1 pt 1.7
notified LR 3 September 2009
s 1, s 2 commenced 3 September 2009 (LA s 75 (1))sch 1 pt 1.7 commenced 4 September 2009 (s 2)
Criminal Code Amendment Regulation 2010 (No 1) SL2010-41
notified LR 25 October 2010
s 1, s 2 commenced 25 October 2010 (LA s 75 (1))
remainder commenced 26 October 2010 (s 2)Criminal Code Amendment Regulation 2013 (No 1) SL2013-10
notified LR 9 May 2013
s 1, s 2 commenced 9 May 2013 (LA s 75 (1))
remainder commenced 10 May 2013 (s 2)Crimes Legislation Amendment Act 2013 (No 2) A2013-50 pt 8
notified LR 9 December 2013
s 1, s 2 commenced 9 December 2013 (LA s 75)pt 8 commenced 10 December 2013 (s 2 (2))
Criminal Code (Controlled Drugs) Legislation Amendment Regulation 2014 (No 1) SL2014-6 pt 2
notified LR 10 April 2014
s 1, s 2 commenced 10 April 2014 (LA s 75 (1))
pt 2 commenced 17 April 2014 (s 2)Crimes Legislation Amendment Act 2019 A2019-23 pt 7
notified LR 8 August 2019
s 1, s 2 commenced 8 August 2019 (LA s 75 (1))
pt 7 commenced 15 August 2019 (s 2 (1))Amendment history
Commencement
s 2om LA s 89 (4)
Dictionary
s 3am SL2014‑6 s 4
Definitions—Code, s 10 (1), def default application date
s 4Ains SL2007‑7 s 4
om A2007‑22 amdt 1.25
ins SL2009‑25 s 4
om A2009‑24 amdt 1.19
ins SL2013‑10 s 4
om A2013‑50 s 21
Controlled drugs—Code, s 600, def controlled drug
s 5am A2008‑26 amdt 2.16
sub SL2010‑41 s 4
Controlled plants—Code, s 600, def controlled plant
s 6am A2008‑26 amdt 2.16
Controlled precursors—Code, s 600, def controlled precursor
s 7am A2008‑26 amdt 2.16
sub SL2010‑41 s 5
Quantities of controlled drugs, plants and precursors—Code, s 601 (1)
s 8am A2008‑26 amdt 2.16; SL2010‑41 s 6, s 7
Quantities of controlled drugs in mixtures—Code, s 601 (2)
s 9am A2008‑26 amdt 2.16
sub SL2014‑6 s 5
Transitional—Criminal Code (Controlled Drugs) Legislation Amendment Regulation 2014 (No 1)
pt 10 hdgins SL2014‑6 s 6
exp 17 April 2016 (s 102)
Meaning of commencement day—pt 10
s 100ins SL2014‑6 s 6
exp 17 April 2016 (s 102)
Application of amendments
s 101ins SL2014‑6 s 6
exp 17 April 2016 (s 102)
Expiry—pt 10
s 102ins SL2014‑6 s 6
exp 17 April 2016 (s 102)
Controlled drugs
sch 1am A2008‑26 amdt 2.17
sub SL2014‑6 s 7
Controlled medicines
sch 1 pt 1.1 hdg sub A2008‑26 amdt 2.18
sch 1 pt 1.1sub SL2014‑6 s 7
Prohibited substances
sch 1 pt 1.2am SL2010‑41 ss 8-10; items renum R9 LA
sub SL2014‑6 s 7
am A2019‑23 s 28
Controlled plants
sch 2sub SL2014‑6 s 7
Controlled precursors
sch 3am SL2008‑56 s 4
sub SL2010‑41 s 11; SL2014‑6 s 7
Dictionary
dictdef associated drug om SL2010‑41 s 12
def cannabis food product ins A2019‑23 s 29
def derivative ins SL2010‑41 s 13
def related drug om SL2010‑41 s 14
Earlier republications
Some earlier republications were not numbered. The number in column 1 refers to the publication order.
Since 12 September 2001 every authorised republication has been published in electronic pdf format on the ACT legislation register. A selection of authorised republications have also been published in printed format. These republications are marked with an asterisk (*) in column 1. Electronic and printed versions of an authorised republication are identical.
Republication No and date Effective Last amendment made by Republication for R1
6 Mar 20056 Mar 2005–
30 Apr 2005not amended new regulation R2
1 May 20051 May 2005–
3 May 2007not amended commenced provision R3
4 May 20074 May 2007–
5 Sept 2007SL2007‑7 amendments by SL2007‑7 R4
6 Sept 20076 Sept 2007–
22 Dec 2008A2007‑22 amendments by A2007‑22 R5
23 Dec 200823 Dec 2008–
13 Feb 2009SL2008‑56 amendments by SL2008‑56 R6
14 Feb 200914 Feb 2009–
1 June 2009SL2008‑56 amendments by A2008‑26 R7
2 June 20092 June 2009–
3 Sept 2009SL2009‑25 amendments by SL2009‑25 R8
4 Sept 20094 Sept 2009–
25 Oct 2010A2009‑24 amendments by A2009‑24 R9*
26 Oct 201026 Oct 2010–
9 May 2013SL2010-41 amendments by SL2010-41 R10
10 May 201310 May 2013–
9 Dec 2013SL2013‑10 amendments by SL2013‑10 R11
10 Dec 201310 Dec 2013–
16 Apr 2014A2013-50 amendments by A2013-50 R12
17 Apr 201417 Apr 2014–
17 Apr 2016SL2014‑6 amendments by SL2014‑6 R13
18 Apr 201618 Apr 2016–
14 Aug 2019SL2014‑6 expiry of transitional provisions (pt 10)
Expired transitional or validating provisions
This Act may be affected by transitional or validating provisions that have expired. The expiry does not affect any continuing operation of the provisions (see Legislation Act 2001, s 88 (1)).
Expired provisions are removed from the republished law when the expiry takes effect and are listed in the amendment history using the abbreviation ‘exp’ followed by the date of the expiry.
To find the expired provisions see the version of this Act before the expiry took effect. The ACT legislation register has point-in-time versions of this Act.
0
0
0